Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedLocations for participating sites across multiple US states (Alabama, California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Tennessee, Wisconsin) and Canadian provinces (Ontario, Quebec) have been added/updated. The page now presents a consolidated list of study locations, reflecting a restructuring of how sites are listed.SummaryDifference0.8%

- Check26 days agoNo Change Detected
- Check48 days agoChange DetectedPublication feed descriptions were updated to indicate that PubMed publications are auto-filled and the page revision label was updated to v3.3.2 (replacing the previous v3.2.0 description). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedRemoval of the government funding status banner (lapse in funding and operating status) from the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedNo additions or deletions were detected for the study details page; the content appears unchanged.SummaryDifference0.2%

- Check98 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check105 days agoChange DetectedUpdated to v3.1.0 and removal of the ovarian cancer resource and older v3.0.2; indicates version upgrade and content trimming.SummaryDifference0.3%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.